- Home
- ALLO vs SCZM Comparison
ALLO vs SCZM Comparison
Compare ALLO & SCZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALLO | SCZM |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | Canada |
| Employees | N/A | 455 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 707.6M | 744.7M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | ALLO | SCZM |
|---|---|---|
| Price | $2.06 | $6.65 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 1 |
| Target Price | $8.35 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 7.8M | 531.8K |
| Earning Date | 05-07-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.09 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $79.38 |
| Revenue Next Year | $142,416.42 | N/A |
| P/E Ratio | ★ N/A | $14.27 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.99 | $5.88 |
| 52 Week High | $4.46 | $17.65 |
Technical Indicators
Market Signals| Indicator | ALLO | SCZM |
|---|---|---|
| Relative Strength Index (RSI) | 52.33 | 40.28 |
| Support Level | $1.85 | $5.88 |
| Resistance Level | $2.36 | $8.77 |
| Average True Range (ATR) | 0.13 | 0.56 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 74.12 | 31.43 |
Price Performance
Historical ComparisonAbout ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
About SCZM Santacruz Silver Mining Ltd. Common Shares
Santacruz Silver Mining Ltd is engaged in the operation, acquisition, exploration, and development of mineral properties in Latin America, with a primary focus on silver and zinc, including lead and copper. The company earns the majority of its revenue from Zinc and Silver. The company's reportable operating segments are the Bolivar mine and processing plant, the Porco mine and processing plant, the Caballo Blanco Group, San Lucas, Zimapa mine and processing plant, and Corporate and Other activities. Key revenue is generated from Zimapan.